Katelyn Griffin
Medical · Birmingham, ALNPI 1770012437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.
Across 185 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$583
- Johnson & Johnson$463
- Sanofi-aventis U.S. LLC$250
- Amgen$239
- Pfizer$196
- E.r. Squibb & Sons, L.L.C.$120
- plus $978 from 26 others
What the payments were for
- Food & beverage$2,829100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 47 | $583 |
| Johnson & Johnson | 31 | $463 |
| Sanofi-aventis U.S. LLC | 14 | $250 |
| Amgen | 17 | $239 |
| Pfizer | 11 | $196 |
| E.r. Squibb & Sons, L.L.C. | 7 | $120 |
| AstraZeneca | 8 | $110 |
| Boehringer Ingelheim | 5 | $98 |
| Amarin Pharma, Inc. | 6 | $84 |
| Lexicon Pharmaceuticals, Inc. | 3 | $62 |
| Merck | 4 | $61 |
| Bayer | 3 | $57 |
| Surmodics, Inc. | 4 | $49 |
| Edwards Lifesciences | 2 | $45 |
| Scpharmaceuticals Inc. | 2 | $41 |
| Biosense Webster, Inc. | 1 | $40 |
| Bridgebio Pharma, Inc. | 2 | $35 |
| Amryt Pharma Holdings Ltd | 2 | $32 |
| Sobi, Inc | 2 | $31 |
| Abbott | 1 | $29 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Sanofi | 1 | $25 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| Akcea Therapeutics, Inc. | 1 | $18 |
| Atricure, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $10 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $7 |
How this compares
$2,829 in reported general payments places this provider in the 75th percentile of 175 medical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Birmingham
- Jaime DunnBirmingham$16K
- Heidi EssigBirmingham$8K
- Laurie WardBirmingham$8K
- Grace McMahanBirmingham$4K
- Sarahreagan HughesBirmingham$4K
- Valentina FolseBirmingham$3K
- Eric PozzoBirmingham$2K
- Allyson LottBirmingham$2K
- Emma StephensBirmingham$2K
- Sara BrownBirmingham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.